Yves Ribeill

Yves Ribeill

Chief Executive Officer at
Ribogenics, Inc.
66 year
Health Technology
Consumer Services
Commercial Services

Profile

Yves Joseph Ribeill is the founder of SCYNEXIS, Inc., founded in 1999, where the title held was Director from 2015 to 2016.
Current jobs include Chief Executive Officer at Enodia Therapeutics, President & Chief Executive Officer at Ribogenics, Inc., President & Chief Executive Officer at COREzonada, Inc. since 2017, and Director at Ogeda SA. Former jobs include Executive Chairman at Calyxt, Inc. in 2021, Director at Synergia Medical SA, Principal at Rhone-Poulenc Rorer, Inc., and Principal at Aventis Pharma SA in 2000.
Education includes a doctorate from Université de Montpellier.

Yves Ribeill active positions

CompaniesPositionStart
Director/Board Member 28/08/2009
Chief Executive Officer 01/08/2017
Chief Executive Officer -

Former positions of Yves Ribeill

CompaniesPositionEnd
SCYNEXIS, INC. Founder 16/03/2016
Corporate Officer/Principal 01/01/2000
Director/Board Member -
Chief Executive Officer 01/10/2018
Corporate Officer/Principal -
See the detail of Yves Ribeill's experience

Training of Yves Ribeill

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

46

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology